Posts by: Patricia Silva PhD

Patricia Silva PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

May 3, 2018May 3, 2018

International Biophysics’ AffloVest Airway Clearance Vest Awarded New US Patents

News

Texas-based International Biophysics recently received two new U.S. patents for its AffloVest High Frequency Chest Wall Oscillation (HFCWO) vest, a type of mobile airway clearance therapy for severe respiratory diseases like ... Read more

February 23, 2018February 23, 2018

Investigational Imaging Technology Allows Deep Look at Lungs, Quickly Detecting Bacteria

News

New medical imaging technology being developed by British researchers allows doctors to see bacteria deep inside patients’ lungs — an unprecedented achievement that may enable detection of harmful bacteria in less ... Read more

January 30, 2018January 30, 2018

Aradigm’s Linhaliq NDA for Non-CF Bronchiectasis Fails to Get FDA Approval

News

The U.S. Food and Drug Administration (FDA) told Aradigm the agency could not approve the company’s New Drug Application (NDA) for Linhaliq in its present form. Linhaliq is designed to treat patients with non-cystic ... Read more

September 26, 2017September 26, 2017

FDA Accepts Aradigm’s New Drug Application for Linhaliq to Treat Non-CF Bronchiectasis

News

A new drug application (NDA) submitted by Aradigm for Linhaliq (inhaled ciprofloxacin) was recently accepted for filing with priority review status by the U.S. Food and Drug Administration (FDA). The NDA ... Read more

August 17, 2017August 17, 2017

Aradigm Awarded Grant to Investigate Treatment of Pulmonary Mycobacterial Infections with Ciprofloxacin Therapies

News

The pharmaceutical company Aradigm was recently awarded a two-year Small Business Initiative Research (SBIR) grant to investigate the company’s inhaled liposomal ciprofloxacin products Linhaliq and Lipoquin as a treatment for two pulmonary non-tuberculous ... Read more

July 25, 2017July 25, 2017

Electromed Launches SmartVest Connect Wireless Technology for Patients with Compromised Pulmonary Function

News

Electromed recently launched its SmartVest Connect wireless technology, to be used with the SmartVest SQL, offering built-in cellular connectivity for healthcare teams and patients to quickly access information that allows for more ... Read more

May 30, 2017May 30, 2017

Dutch Conglomerate Philips Acquires RespirTech, Expands Portfolio of Devices for Patients with Bronchiectasis, COPD

News

Dutch healthcare giant Royal Philips has agreed to acquire Respiratory Technologies (RespirTech), a St. Paul, Minnesota-based maker of innovative airway clearance devices for patients with bronchiectasis and other respiratory illnesses. RespirTech, founded in 2004, offers a robust ... Read more

April 27, 2017April 27, 2017

CPAG Calls for Greater Efforts to Combat Childhood Bronchiectasis in New Zealand

News

The high rates of childhood bronchiectasis in New Zealand should encourage the government to increase spending on children’s health, according to the Child Poverty Action Group (CPAG). This call from CPAG, ... Read more

April 13, 2017April 13, 2017

UK Beauty Queen to Raise Awareness of Bronchiectasis on Trip to Ghana

News

A British beauty pageant winner will be raising awareness of a lung disease known as bronchiectasis, which she developed as a child, during a trip to the country of her ... Read more